Retour
Fourchette du Jour
13,32 €
14,52 €
Fourchette 52 Semaines
2,54 €
26,95 €
Volume
1 285 542
Moyenne 50J / 200J
16,97 €
/
8,91 €
Clôture Précédente
13,15 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -78,2 | 0,2 |
| P/B | 19,5 | 3,0 |
| ROE % | -32,6 | 3,5 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 9,7 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
31,80 €
+123.6%
Low: 27,00 €
High: 42,00 €
BPA Prévisionnel
-0,69 €
CA Est.
1,18M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,12 €
0,10 € – 0,14 €
|
235,81M | 2 |
| FY2029 |
-0,46 €
-0,53 € – -0,38 €
|
130,10M | 4 |
| FY2028 |
-0,64 €
-1,56 € – 0,05 €
|
58,15M | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-12 | -0,13 € | -0,15 € | -15,9% |
| 2025-11-04 | -0,14 € | -0,12 € | +14,3% |
| 2025-08-07 | -0,13 € | -0,10 € | +23,1% |
| 2025-05-08 | -0,13 € | -0,13 € | 0,0% |
| 2025-03-25 | -0,12 € | -0,18 € | -50,0% |
| 2024-11-12 | -0,11 € | -0,11 € | 0,0% |
| 2024-08-06 | -0,12 € | -0,07 € | +41,7% |
| 2024-05-06 | -0,12 € | -0,12 € | 0,0% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -32,97M
PEG of 0,49 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-32,60%
ROIC-51,86%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,02
Current Ratio6,21
Interest Coverage0,00
Valorisation
P/E Ratio
-78,15
Forward P/EN/A
P/B Ratio19,51
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -15,28M |
| ROE | -32,60% | ROA | -21,49% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -32,97M |
| ROIC | -51,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 6,21 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -78,15 | Forward P/E | N/A |
| P/B Ratio | 19,51 | P/S Ratio | N/A |
| PEG Ratio | 0,49 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1012,18 | Fwd Earnings Yield | N/A |
| FCF Yield | -2,76% | ||
| Market Cap | 1,19B | Enterprise Value | 1,19B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -15,28M | -62,29M | -27,03M | -41,31M | -43,24M |
| EPS (Diluted) | -0,53 | -1,02 | -0,56 | -0,89 | -1,03 |
| Gross Profit | -105 000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -42,97M | -27,55M | -23,41M | -32,57M | -38,63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 71,12M | 68,91M | 45,55M | 68,24M | 109,46M |
| Total Liabilities | 9,91M | 36,34M | 6,87M | 12,13M | 12,29M |
| Shareholders' Equity | 61,21M | 32,57M | 38,68M | 56,12M | 97,16M |
| Total Debt | 937 000,0 | 1,12M | 1,37M | 2,60M | 3,65M |
| Cash & Equivalents | 4,58M | 8,74M | 12,62M | 13,16M | 63,46M |
| Current Assets | 58,21M | 54,41M | 27,96M | 43,66M | 71,31M |
| Current Liabilities | 9,38M | 35,40M | 6,87M | 10,75M | 9,69M |